SCHEMBL9890248

SCHEMBL9890248

c1ccc(-c2cccc(-c3ccc4sc5cc6c(cc5c4c3)sc3ccc(-n4c5ccccc5c5ccccc54)cc36)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
LIMK1 P53667 2/20 0.36
HDAC4 P56524 1/20 0.36
PIM3 Q86V86 1/20 0.35
TSPO P30536 1/20 0.33
ROCK1 Q13464 1/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
HTR7 P34969 1/20 0.31
OPRD1 P41143 1/20 0.31
KMT2A Q03164 2/20 0.31
F9 P00740 1/20 0.31
GPR3 P46089 1/20 0.31
IL1R1 P14778 1/20 0.31
ALDH1A1 P00352 2/20 0.30
MAPT P10636 2/20 0.30
HPGD P15428 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17228717 0.97 L3MBTL1 (0.43) L3MBTL1KDM4EATMLIMK1HDAC4
SCHEMBL17228706 0.97 L3MBTL1 (0.43) L3MBTL1KDM4EATMLIMK1HDAC4
SCHEMBL17166663 0.97 L3MBTL1 (0.43) L3MBTL1KDM4EATMLIMK1HDAC4
SCHEMBL9890500 0.96 KDM4E (0.40) L3MBTL1KDM4EATMLIMK1HDAC4
SCHEMBL17228735 0.95 KDM4E (0.41) L3MBTL1KDM4EATMLIMK1HDAC4
SCHEMBL17166681 0.95 KDM4E (0.41) L3MBTL1KDM4EATMLIMK1HDAC4
SCHEMBL17166715 0.95 KDM4E (0.41) L3MBTL1KDM4EATMLIMK1HDAC4
SCHEMBL14867940 0.95 KDM4E (0.41) L3MBTL1KDM4EATMLIMK1HDAC4
SCHEMBL17166790 0.95 KDM4E (0.41) L3MBTL1KDM4EATMLIMK1HDAC4
SCHEMBL20277233 0.94 L3MBTL1 (0.46) L3MBTL1KDM4EATMLIMK1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 L3MBTL1 709/4885KDM4E 990/4885ATM 3103/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 L3MBTL1 709/4885KDM4E 990/4885ATM 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.